Li, Huangcan http://orcid.org/0000-0003-1409-9219
Wang, Xiong
Wang, Yiran
Li, Yichen
Chen, Ying
Wong, Yin-Ting
He, Jufang
He, Ming-Liang
Funding for this research was provided by:
Shenzhen Science and Technology Innovation Commission (JCYJ20180507181627057)
City University of Hong Kong
RGC General Research Fund of Hong kong Special Administrative Region
Article History
Received: 29 October 2022
Revised: 4 July 2023
Accepted: 30 August 2023
First Online: 25 September 2023
Competing interests
: M.L.H., H.L. and X.W. are inventors of US patent application no. 63/500,277 in May 2023. Title: Method of use LRPAP1 inhibitors against multiple virus infections. The others declare no competing interests. M.L.H. is one of the editorial board members in <i>Signal Transduction and Targeted Therapy</i> and he has not been involved in the process of the manuscript handling.